(Q34330092)

English

Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Epstein–Barr virus

0 references

1 reference

based on heuristic

inferred from title

author name string

Mentzer SJ

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Perrine SP

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Faller DV

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

177-185

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

A sarcoma involving the jaws in African children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

CULTIVATION IN VITRO OF HUMAN LYMPHOBLASTS FROM BURKITT'S MALIGNANT LYMPHOMA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Reticulum Cell Sarcoma after Renal Homotransplantation and Azathioprine and Prednisone Therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Pseudolymphoma in Renal Allograft Recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

The role of EBV in post-transplant malignancies: a review

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Chronic, active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Early events in Epstein-Barr virus infection of human B lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Replication of the resident repressed Epstein-Barr virus genome during the early S phase (S-1 period) of nonproducer Raji cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Necrotic, ulcerative bronchitis, the presenting feature of lymphoproliferative disease following heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Simultaneous development of diffuse immunoblastic lymphoma in recipients of renal transplants from a single cadaver donor: transmission of Epstein-Barr virus and triggering by OKT3.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Rapidly growing Epstein-Barr virus-associated pulmonary lymphoma after heart transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Posttransplant T-cell lymphoma. Report of three cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Immunoblastic lymphoma of donor origin in the allograft after lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

The molecular genetics of post-transplantation lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Epstein-Barr virus induces a unique pyrimidine deoxynucleoside kinase activity in superinfected and virus-producer B cell lines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retroviral vectors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Effects of n-Butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Butryic acid analogues augment gamma globin gene expression in neonatal erythroid progenitors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

A possible association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

21 January 2018

Epstein-Barr virus and the immune system. Hide and seek

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr Virus Lymphoproliferative Disease Associated with Acquired Immunodeficiency

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A poorly differentiated lymphoma of donor origin in a renal allograft recipient.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of sodium butyrate in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Butyrate in the treatment of sickle cell disease and beta-thalassemia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003177.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-3062.2001.003003177.X

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34330092&oldid=2046494953"